chr9-104806276-A-G
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_005502.4(ABCA1):c.4429T>C(p.Cys1477Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Consequence
NM_005502.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypoalphalipoproteinemia, primary, 1Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Tangier diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- apolipoprotein A-I deficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ABCA1 | ENST00000374736.8 | c.4429T>C | p.Cys1477Arg | missense_variant | Exon 31 of 50 | 1 | NM_005502.4 | ENSP00000363868.3 | ||
| ABCA1 | ENST00000678995.1 | c.4435T>C | p.Cys1479Arg | missense_variant | Exon 31 of 50 | ENSP00000504612.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152162Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461516Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727062 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74338 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
ABCA1-related disorder Pathogenic:1
The ABCA1 c.4429T>C variant is predicted to result in the amino acid substitution p.Cys1477Arg. This variant has been reported in the heterozygous state in multiple individuals with high-density lipoprotein deficiency (reported as p.Cys1417Arg in Figure 3, Brooks-Wilson et al. 1999. PubMed ID: 10431236; Table 1, Candini et al. 2010. PubMed ID: 20880529) and it has also been reported in the compound heterozygous state in an individual with Tangier disease (Table 1, Haidar et al. 2003. PubMed ID: 14701824). This variant has not been reported in a large population database, indicating this variant is rare. In vitro experimental studies suggest this variant impacts ApoA1 binding, phosphocholine transport, and cholesterol transport (Figure 3, Singaraja et al. 2006. PubMed ID: 16873719; Quazi et al. 2013. PubMed ID: 24097981). An alternate nucleotide change at the same amino acid (p.Cys1477Phe), has been reported in multiple individuals with high-density lipoprotein deficiency (Table 3, Cohen et al. 2004. PubMed ID: 15297675; Table 1, Berge et al. 2010. PubMed ID: 20800056). The c.4429T>C (p.Cys1477Arg) variant is interpreted as pathogenic. -
Tangier disease Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at